These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10230308)

  • 21. Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir.
    McCance-Katz EF; Moody DE; Smith PF; Morse GD; Friedland G; Pade P; Baker J; Alvanzo A; Jatlow P; Rainey PM
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S235-46. PubMed ID: 17109310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid withdrawal syndrome on switching from hydromorphone to alfentanil.
    McMunnigall F; Welsh J
    Palliat Med; 2008 Mar; 22(2):191-2. PubMed ID: 18372384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lopinavir/ritonavir- and indinavir-induced thrombocytopenia in a patient with HIV infection.
    Colebunders R; De Schacht C; Vanwolleghem T; Callens S
    Int J Infect Dis; 2004 Sep; 8(5):315-6. PubMed ID: 15325601
    [No Abstract]   [Full Text] [Related]  

  • 24. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X; Khazaal Y; Besson J; Zullino DF
    Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyponatraemia associated with lopinavir--ritonavir?
    Roberts MT; Aliyu SH
    Int J Infect Dis; 2007 Jan; 11(1):83-4. PubMed ID: 16574455
    [No Abstract]   [Full Text] [Related]  

  • 26. Ritonavir and fluticasone: beware of this potentially fatal combination.
    Li AM
    J Pediatr; 2006 Mar; 148(3):294-5. PubMed ID: 16615953
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.
    Lewanowitsch T; Miller JH; Irvine RJ
    Life Sci; 2006 Jan; 78(7):682-8. PubMed ID: 16102783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alopecia associated with ritonavir-boosted atazanavir therapy.
    Torres HA; Barnett BJ; Arduino RC
    AIDS; 2007 Jun; 21(10):1391-2. PubMed ID: 17545728
    [No Abstract]   [Full Text] [Related]  

  • 29. Ritonavir-boosted atazanavir, methadone, and ventricular tachycardia: 2 case reports.
    Gallagher DP; Kieran J; Sheehan G; Lambert J; Mahon N; Mallon PW
    Clin Infect Dis; 2008 Aug; 47(3):e36-8. PubMed ID: 18558878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interaction between methadone and antiretrovirals (stavudine, indinavir, ritonavir, nevirapine)].
    de la Cruz Pellín M; Esteban J; Gimeno C; Mora E
    Med Clin (Barc); 2003 Oct; 121(11):439. PubMed ID: 14563283
    [No Abstract]   [Full Text] [Related]  

  • 31. Neurobehavioral effects of treatment for opiate withdrawal.
    Coyle MG; Ferguson A; Lagasse L; Liu J; Lester B
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F73-4. PubMed ID: 15613582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Withdrawal syndrome from tramadol hydrochloride.
    Barsotti CE; Mycyk MB; Reyes J
    Am J Emerg Med; 2003 Jan; 21(1):87-8. PubMed ID: 12563592
    [No Abstract]   [Full Text] [Related]  

  • 33. [Dependence after treatment with tramadol].
    Jensen JB
    Ugeskr Laeger; 1997 Feb; 159(6):785. PubMed ID: 9045476
    [No Abstract]   [Full Text] [Related]  

  • 34. Withdrawal symptoms during chronic transdermal fentanyl administration managed with oral methadone.
    Ripamonti C; Campa T; De Conno F
    J Pain Symptom Manage; 2004 Mar; 27(3):191-4. PubMed ID: 15010096
    [No Abstract]   [Full Text] [Related]  

  • 35. Opioid withdrawal due to Twiddler syndrome.
    Moens M; De Smedt A; Brouns R
    Neurology; 2011 Jul; 77(1):86. PubMed ID: 21727267
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
    Glasper A; Gossop M; de Wet C; Reed L; Bearn J
    Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Is premature termination of opiate detoxification due to intensive withdrawal or craving?].
    Scherbaum N; Heppekausen K; Rist F
    Fortschr Neurol Psychiatr; 2004 Jan; 72(1):14-20. PubMed ID: 14745685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychotic symptoms following buprenorphine withdrawal.
    Karila L; Berlin I; Benyamina A; Reynaud M
    Am J Psychiatry; 2008 Mar; 165(3):400-1. PubMed ID: 18316438
    [No Abstract]   [Full Text] [Related]  

  • 40. Acquired macroglossia due to lopinavir/ritonavir treatment.
    Vritsali E; Kolokotronis A; Valagouti D; Miteloudis G; Zaraboukas T; Kioses V; Antoniades D
    J Oral Pathol Med; 2005 Jan; 34(1):56-8. PubMed ID: 15610408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.